Q2 2016 13F Holders as of 30 Jun 2016
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
8.56M
-
Number of holders
-
70
-
Total 13F shares, excl. options
-
21.6M
-
Shares change
-
+1.96M
-
Total reported value, excl. options
-
$486M
-
Value change
-
+$46.7M
-
Number of buys
-
50
-
Number of sells
-
-14
-
Price
-
$22.51
Significant Holders of Atara Biotherapeutics, Inc. - Common Stock (ATRA) as of Q2 2016
77 filings reported holding ATRA - Atara Biotherapeutics, Inc. - Common Stock as of Q2 2016.
Atara Biotherapeutics, Inc. - Common Stock (ATRA) has 70 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 21.6M shares
.
Largest 10 shareholders include BAUPOST GROUP LLC/MA (5.36M shares), FMR LLC (3.13M shares), Redmile Group, LLC (2.41M shares), Arrowpoint Asset Management, LLC (1.25M shares), UBS ASSET MANAGEMENT AMERICAS INC (1.15M shares), BRIDGER MANAGEMENT, LLC (1.02M shares), EAGLE ASSET MANAGEMENT INC (973K shares), BlackRock Fund Advisors (914K shares), VANGUARD GROUP INC (680K shares), and Neuberger Berman Group LLC (629K shares).
This table shows the top 70 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.